Kurome Therapeutics Announces FDA Clearance of IND Application for KME-0584
15 Feb 2024 //
BUSINESSWIRE
Kurome Announces Presentations on Dual IRAK1/4 Inhibitors at Meeting
06 Dec 2022 //
BUSINESSWIRE
15 Feb 2024 //
BUSINESSWIRE
06 Dec 2022 //
BUSINESSWIRE